Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

Christos Demosthenous(Mayo Clinic), Mamta Gupta(George Washington University)
Oncotarget
March 20, 2015
Cited by 32


Related Papers